Results 31 to 40 of about 963 (180)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study

Perspectives in Clinical Research, 2023
Purpose: Bilastine is a novel second-generation antihistaminic. Very few studies in Indian population have compared the safety and efficacy of bilastine with other second-generation antihistaminic like cetirizine.
Vishakha V Sinha, Mrunalini Vinay Kalikar, Jayesh Ishwardas Mukhi, Akhil Bhagwan Giradkar, Smita Sontakke   +4 more
doaj   +1 more source

Efficacy of Oral Bilastine in Comparison to Levocetirizine in Allergic RhinitisA Randomised Clinical Study [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Allergic rhinitis is a heterogeneous disorder characterised by major symptoms like sneezing, itching, nasal congestion and rhinorrhea.
M VANITHA, K SOWMINI, K SANTHA SHEELA KUMARI, Resu Neha Reddy   +3 more
doaj   +1 more source

Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine. [PDF]

Headache
Abstract Objective To characterize clinical presentation and management of urticaria associated with calcitonin gene‐related peptide (CGRP) ‐targeting monoclonal antibodies (mAbs) for migraine prophylaxis. Background CGRP‐targeting mAbs are effective in migraine prophylaxis, but have been associated with hypersensitivity reactions, including urticaria.
Berger CT, Villena FB, Vogt SB, Heydrich L, Hartmann K, Papadopoulou A.   +5 more
europepmc   +2 more sources

Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers : A Wheal and Flare Study [PDF]

, 2022
The aim of this study was to compare the pharmacodynamic activity of bilastine administered under fasting and fed conditions in healthy volunteers. In this randomized, open-label, two-period, crossover study involving 24 healthy subjects, once-daily oral
Labeaga, Luis, Gich, Ignasi, Martínez, Joan, Antonijoan Arbós, Rosa Ma (Rosa María), Coimbra, Jimena, Molina, Pol, Puntes, Montserrat, Campo, Cristina   +7 more
core   +1 more source

Theoretical and experimental study of bilastine ionization [PDF]

, 2023
The protolytic equilibria of bilastine were studied experimentally and theoretically. The pKa values were determined potentiometrically at a constant ionic strength (0.1 M NaCl) and temperature 25 °C.
Popović-Nikolić, Marija, Nikolić, Katarina, Popović, Gordana, Oljačić, Slavica   +3 more
core   +1 more source

Bilastin [PDF]

pharma-kritik, 2012
Ein neues Antihistaminikum, das bei allergischer Rhinitis und Urtikaria ähnlich wie andere sogen. nicht-sedierende Antihistaminika – z.B. Cetirizin – die Symptome lindert. Es unterscheidet sich nicht wesentlich von anderen Substanzen dieser Gruppe.
openaire   +1 more source

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Allergology International, 2017
Background: Bilastine, a novel non-sedating second-generation H1 antihistamine, has been approved in most European countries since 2010. This study aimed to evaluate the superiority of bilastine over placebo in Japanese patients with perennial allergic ...
Kimihiro Okubo, Minoru Gotoh, Mikiya Asako, Yasuyuki Nomura, Michinori Togawa, Akihiro Saito, Takayuki Honda, Yoshihiro Ohashi   +7 more
doaj   +1 more source

Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report. [PDF]

Allergy
This study compares different medications for allergic rhinitis on patients' satisfaction and co‐medication use frequency. mHealth data suggest that intranasal corticosteroids (INCS) and fixed combinations of intranasal antihistamines (INAH) and corticosteroids are associated with higher treatment satisfaction than oral antihistamines (OAH).
Sousa-Pinto B, Vieira RJ, Bognanni A, Martini M, Ordak M, Paoletti G, Gil-Mata S, Amaral R, Bedbrook A, Bonadonna P, Brussino L, Canonica GW, Coutinho-Almeida J, Cruz ÁA, Czarlewski W, Dykewicz M, Giovannini M, Gemicioglu B, Ivancevich JC, Klimek L, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Moreira A, Niedoszytko M, Pereira AM, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Thomander T, Koyuncu IV, Valiulis A, Vecillas LL, Ventura MT, Walusiak-Skorupa J, Xiang YK, Pfaar O, Fonseca JA, Zuberbier T, Schünemann HJ, di Bona D, Bousquet J.   +45 more
europepmc   +2 more sources

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.

, 2021
Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formulation of ...
Mejía-Abril, Gina, Fernández, Nieves, Abad-Santos, Francisco, Elgezabal, Lorena, Arranz, Paula, Ochoa, Dolores, Román, Manuel, Belmonte, Carmen, Martín-Vilchez, Samuel, Hernández, Gonzalo   +9 more
core   +1 more source

Stability and Degradation Kinetic study of Bilastine in Solution State by RP-HPLC Method [PDF]

, 2021
Aim: The current study dealt with the degradation behavior of Bilastine and degradation kinetics of a drug in solution state. Background:  Very limited information on the effect of pH on maximum stability has been published.
Gupta, Krishna R, Tembhare, Ekta P, Ganorkar, Anvesha V, Karemore, Heera, Umekar, Milind J   +4 more
core   +1 more source